JP2010518158A5 - - Google Patents

Download PDF

Info

Publication number
JP2010518158A5
JP2010518158A5 JP2009549593A JP2009549593A JP2010518158A5 JP 2010518158 A5 JP2010518158 A5 JP 2010518158A5 JP 2009549593 A JP2009549593 A JP 2009549593A JP 2009549593 A JP2009549593 A JP 2009549593A JP 2010518158 A5 JP2010518158 A5 JP 2010518158A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
hetaryl
pharmaceutical composition
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009549593A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010518158A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/001748 external-priority patent/WO2008100448A2/en
Publication of JP2010518158A publication Critical patent/JP2010518158A/ja
Publication of JP2010518158A5 publication Critical patent/JP2010518158A5/ja
Pending legal-status Critical Current

Links

JP2009549593A 2007-02-13 2008-02-08 成長ホルモン分泌促進物質を用いた細胞増殖性障害の治療方法 Pending JP2010518158A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90160907P 2007-02-13 2007-02-13
PCT/US2008/001748 WO2008100448A2 (en) 2007-02-13 2008-02-08 Method of treating cell proliferative disorders using growth hormone secretagogues

Publications (2)

Publication Number Publication Date
JP2010518158A JP2010518158A (ja) 2010-05-27
JP2010518158A5 true JP2010518158A5 (US07846941-20101207-C00217.png) 2011-03-31

Family

ID=39690677

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009549593A Pending JP2010518158A (ja) 2007-02-13 2008-02-08 成長ホルモン分泌促進物質を用いた細胞増殖性障害の治療方法

Country Status (12)

Country Link
US (1) US20080207640A1 (US07846941-20101207-C00217.png)
EP (1) EP2134341B1 (US07846941-20101207-C00217.png)
JP (1) JP2010518158A (US07846941-20101207-C00217.png)
KR (1) KR20090112720A (US07846941-20101207-C00217.png)
CN (1) CN101686966A (US07846941-20101207-C00217.png)
AU (1) AU2008216789A1 (US07846941-20101207-C00217.png)
CA (1) CA2677813A1 (US07846941-20101207-C00217.png)
EA (1) EA200970764A1 (US07846941-20101207-C00217.png)
IL (1) IL200367A0 (US07846941-20101207-C00217.png)
MX (1) MX2009008561A (US07846941-20101207-C00217.png)
TW (1) TWI450719B (US07846941-20101207-C00217.png)
WO (1) WO2008100448A2 (US07846941-20101207-C00217.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX341660B (es) * 2010-02-26 2016-08-29 Raqualia Pharma Inc Agonista del receptor de ghrelina para el tratamiento de caquexia.
JO3353B1 (ar) 2012-04-20 2019-03-13 Ono Pharmaceutical Co شكل صلب معزول من أحادي هيدروكلوريد أناموريلين بنسبة مولارية منخفضة من الكلوريد: أناموريلين ومحتوى منخفض من مذيب عضوي متبقي
PT3466930T (pt) 2013-02-08 2022-08-19 Gen Mills Inc Produto alimentar com baixo teor de sódio
AP2017009772A0 (en) * 2014-09-04 2017-02-28 Helsinn Healthcare Sa Medical treatments based on anamorelin
TW202246215A (zh) 2015-12-18 2022-12-01 美商亞德利克斯公司 作為非全身tgr5促效劑之經取代之4-苯基吡啶化合物
US20220323430A1 (en) 2019-08-30 2022-10-13 Helsinn Healthcare Sa Methods of manufacturing anamorelin tablets having improved stability
CA3162166A1 (en) 2019-12-02 2021-06-10 Storm Therapeutics Limited Polyheterocyclic compounds as mettl3 inhibitors

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112112A (en) * 1993-12-23 2000-06-29 Novo Nordisk As Peptides with growth hormone releasing properties and pharmaceutical compositions containing them
CZ195098A3 (cs) * 1995-12-22 1998-10-14 Novo Nordisk A/S Sloučeniny uvolňující růstový hormon
US5922770A (en) * 1996-07-22 1999-07-13 Novo Nordisk A/S Compounds with growth hormone releasing properties
US6566334B1 (en) * 1997-02-06 2003-05-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Short amphipathic peptides with activity against bacteria and intracellular pathogens
US6286927B1 (en) * 1997-12-25 2001-09-11 Canon Kabushiki Kaisha Ink jet element substrate and ink jet head that employs the substrate, and ink jet apparatus on which the head is mounted
US6494563B2 (en) * 1997-12-25 2002-12-17 Canon Kabushiki Kaisha Ink jet element substrate and ink jet head that employs the substrate, and ink jet apparatus on which the head is mounted
US6083908A (en) * 1998-01-16 2000-07-04 Novo Nordisk A/S Compounds with growth hormone releasing properties
US6303620B1 (en) * 1998-05-11 2001-10-16 Novo Nordisk A/S Compounds with growth hormone releasing properties
US6124263A (en) 1998-11-16 2000-09-26 Asta Medica Ag Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
US6919315B1 (en) 1998-06-30 2005-07-19 Novo Nordisk A/S Compounds with growth hormone releasing properties
US6566337B1 (en) * 1998-11-03 2003-05-20 Novo Nordisk A/S Compounds with growth hormone releasing properties
UA73530C2 (uk) 1999-11-10 2005-08-15 Ново Нордіск А/С Сполука з властивостями вивільнювати гормон росту
DE60140285D1 (de) * 2000-05-31 2009-12-10 Pfizer Prod Inc Verwendung von Wachstumshormonsekretagoga zur Förderung der Beweglichkeit des Verdauungstrakts
ES2330193T3 (es) * 2000-06-07 2009-12-07 Merck Serono Sa Hormona de crecimiento humano para estimular la movilizacion de celulas madre hematopoyeticas pluripotentes.
WO2002070511A1 (en) * 2001-03-02 2002-09-12 Bristol-Myers Squibb Company Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
EP1312363A1 (en) * 2001-09-28 2003-05-21 Pfizer Products Inc. Methods of treatment and kits comprising a growth hormone secretagogue
US7491695B2 (en) 2003-06-18 2009-02-17 Tranzyme Pharma Inc. Methods of using macrocyclic modulators of the ghrelin receptor
JP2007531769A (ja) * 2004-03-30 2007-11-08 サファイア セラピューティクス インコーポレイテッド 成長ホルモン分泌促進薬を使用したc−反応性蛋白質の低減方法
ES2602789T3 (es) * 2007-02-09 2017-02-22 Ocera Therapeutics, Inc. Productos intermedios conectores para la síntesis de moduladores macrocíclicos del receptor de la grelina

Similar Documents

Publication Publication Date Title
JP2010518158A5 (US07846941-20101207-C00217.png)
JP2020502049A5 (US07846941-20101207-C00217.png)
JP2020517616A5 (US07846941-20101207-C00217.png)
JP2019512478A5 (US07846941-20101207-C00217.png)
JP2019513734A5 (US07846941-20101207-C00217.png)
JP2016519062A5 (US07846941-20101207-C00217.png)
JP2014513704A5 (US07846941-20101207-C00217.png)
JP2018504378A5 (US07846941-20101207-C00217.png)
JP2007511504A5 (US07846941-20101207-C00217.png)
JP2019524883A5 (US07846941-20101207-C00217.png)
JP2009526034A5 (US07846941-20101207-C00217.png)
JP2008525417A5 (US07846941-20101207-C00217.png)
JP2008535902A5 (US07846941-20101207-C00217.png)
JP2018507197A5 (US07846941-20101207-C00217.png)
JP2018524403A5 (US07846941-20101207-C00217.png)
JP2007523941A5 (US07846941-20101207-C00217.png)
JP2008505117A5 (US07846941-20101207-C00217.png)
JP2011517453A5 (US07846941-20101207-C00217.png)
JP2011251990A5 (US07846941-20101207-C00217.png)
JP2005518382A5 (US07846941-20101207-C00217.png)
JP2017509689A5 (US07846941-20101207-C00217.png)
RU2012149448A (ru) Новые конъюгаты аналогов сс-1065 и бифункциональные линкеры
JP2008505194A5 (US07846941-20101207-C00217.png)
JP2009539943A5 (US07846941-20101207-C00217.png)
JP2013510178A5 (US07846941-20101207-C00217.png)